Meinian Health won the "2024 Forbes Chinese Artificial Intelligence Innovation Scenario Application Enterprise TOP10" award

　　Recently, the results of the 2024 Forbes Chinese Artificial Intelligence Technology Enterprise TOP50 list were announced, and Meinian Health Industry Holdings Co., Ltd. (hereinafter referred to as "Meinian Health") won the "2024 Forbes Chinese Artificial Intelligence Innovation Scene Application Enterprise Top10" sub-selection award, which aims to recognize enterprises with outstanding performance in artificial intelligence technology research and development and scene application, including the innovative achievements of AI artificial intelligence technology widely used in entertainment, kitchen, home management, It is an excellent company that greatly enriches people's life experience in the field of medical care and other life scenarios.

　　Forbes China has a long-standing commitment to understanding the major changes in business and industry. In order to showcase the benchmark enterprises and figures that have made remarkable achievements in the field of artificial intelligence, and share their success models and development paths, Forbes China officially launched the "2024 Forbes Chinese Artificial Intelligence Technology Enterprise TOP 50 Selection" activity. The selection lasted for 7 months, and conducted in-depth research and analysis in many aspects such as the technological development, application scenarios, industrial ecology and market scale of the artificial intelligence industry. Regarding the selection of the "2024 Forbes Chinese Artificial Intelligence Innovation Scenario Application Enterprise Top 10" award, the jury mainly examines and evaluates the application cases of enterprise innovation scenarios, as well as their industry impact and social benefits.

　　Forbes, the organizer, said that as a selected enterprise in the selection of innovative scenario applications, Meinian Health is a large-scale health examination and medical group in China. In the past three years, it has comprehensively improved the application scenarios of AI technology, covering AI+ brain health, fundus, breast ultrasound AI, lung health AI diagnosis, AI-MDT intelligent reporting, digital intelligent health management and other fields, and has made remarkable achievements in accurate screening and auxiliary decision-making, and has landed in more than 200 cities.

　　Extensive use of AI technology to launch innovative products to enable precise prevention

　　Since 2017, Meinian has been implementing AI applications, using artificial intelligence and AI technology to assist in diagnosis, improve the efficiency of film reading, and upgrade medical quality management. In various professional disciplines, in recent years, Meinian Health has integrated AI technology into its "specialized, special and new" series of innovative products. In the field of imaging, the company has introduced the AI lung-imaging e+ retrospective pulmonary nodule in-depth analysis and reporting system and the AI cardio-coronary calcification integral CT intelligent evaluation project to assist doctors in accurately diagnosing lung diseases and cardiovascular diseases. In the field of ophthalmology, the introduction of AIXI's ™ retinal artificial intelligence screening products can efficiently screen fundus diseases such as diabetic retinopathy and glaucoma. In the field of nervous system, the first innovative product focusing on early screening of stroke and Alzheimer's disease was launched, based on high-precision brain magnetic resonance imaging, using artificial intelligence image analysis technology and the whole brain standard database of all ages in healthy people in China, to identify structural abnormalities and functional degeneration in the early stage of brain disease. At present, Meinian Health has used AI technology to significantly improve the accuracy and efficiency of screening in key items such as pulmonary nodules, cardiovascular, fundus, ultrasound, and children's bone age assessment. These new innovative products not only bring a good experience to customers, but also reflect Meinian's unique technology label.

　　The AI application of full-cycle health management leads the development of personalized and digital intelligence of health examinations

　　Meinian Health uses AI and big data technology to promote the innovation of the physical examination industry, leading the health examination industry into the era of personalization and digital intelligence, and building a new model of health management. Starting from 2022, Meinian Health has begun to provide personalized medical examination services driven by AI algorithm models, and individual customers and group customers can use artificial intelligence technology to customize medical examination packages based on historical data and simple questionnaires. At present, Meinian Health has fully realized the application of AI and big data before, during and after the examination. In the examination, whether it is auxiliary medical treatment, innovative products or time-sharing appointment to improve customer feelings, AI technology has been fully applied, post-examination intelligent main examination and multidisciplinary health intelligent assessment can greatly improve the efficiency and accuracy of diagnosis and treatment, and at the same time provide detailed data basis and user tags for health intervention; Finally, in the health intervention stage, on the basis of providing medical channels, expert docking, insurance products and other services, we will gradually explore solutions for different chronic disease management assisted by AI and big data。

　　Based on large-scale model technology, we will create new tools and new paradigms for health management in the era of large-scale models

　　As a leading enterprise in the field of preventive medicine, Meinian Health actively embraces the era of large models, and proposes to fully implement the AII IN AI strategy in 2024, through the application research of AIGC technology and artificial intelligence in the field of physical examination, accelerate the implementation of AIGC medical and health ecology and health management models, promote the continuous innovation of medical service models and products, create new tools and paradigms for health management in the era of large models, and provide more accurate, efficient and personalized health services for the public.

　　In January 2024, Meinian Health reached a strategic cooperation with HUAWEI CLOUD and Runda Medical, and the three parties announced that they would jointly build the first health management AI robot in China - "Healthy Xiaomei" digital intelligent health manager, using advanced generative AI technology and accurate data-driven services, "Healthy Xiaomei" can provide users with personalized health management suggestions, plans and services, and combine the latest medical research results to tailor health management plans for users, adjust and optimize suggestions in a timely manner to adapt to changes in users' health status. Meinian Health hopes to create a new digital health management platform for customers with all-round and full life cycle through the "Healthy Xiaomei" digital intelligent health manager, effectively improve the efficiency of health prevention and disease management, and bring a new health management experience to individuals and physical examination institutions. The beta version of "Healthy Xiaomei" Digital Intelligence Health Manager has been officially launched on April 15, 2024, and Meinian Health will officially release the "Healthy Xiaomei" product at the end of June 2024, and it will be launched for trial in multiple cities at that time.

　　With the popularization of AI technology, Meinian Health is committed to further exploring the value of health big data through AIGC technology, giving full play to the advantages of Meinian health data, and realizing productization as soon as possible. Based on the application research of AIGC technology and artificial intelligence model in the health examination industry, we will launch "Healthy Xiaomei" digital intelligent health manager, digital health person, AI report interpretation, AI mental health, AI health insurance and other products to create AI capabilities with industry-leading advantages and comprehensively improve service quality and customer experience. Reduce costs and increase efficiency internally, and innovate products externally".

　　Meinian believes that artificial intelligence has good application scenarios and business scenarios in the field of health examination. In the future, Meinian Health will further explore the value of health big data through AI artificial intelligence technology, focus on the whole process of physical examination, as well as more AI innovative application scenarios in the core directions of post-examination specialty, genetic testing, and chronic disease management, and strive to build a leading "AI + health management" benchmarking platform in China, comprehensively improve service quality and customer experience, meet customers' all-round and full-cycle health management needs, and help the health examination industry to upgrade to digital and intelligent health management.